Semaglutide (10mg / 20mg / 30mg) — Research Peptide

Semaglutide (CAS 910463-68-2) is a synthetic research peptide supplied by Eclipse Peptides as a high-purity reference compound for in-vitro laboratory study. It is characterized by the molecular formula C187H291N45O59 and a molecular weight of 4113.58 g/mol, provided as a white lyophilized powder at a minimum purity of >99%.

Semaglutide is studied in the context of metabolic research and remains an active area of scientific investigation. Eclipse supplies Semaglutide strictly as a reference material for research applications. Each batch is third-party tested and ships with a Certificate of Analysis. Store lyophilized at 2–8°C.

This product is for in-vitro research use only. It is not a drug, supplement, or medical product and is not intended for human or animal consumption.

Semaglutide is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1) currently being studied for its activity at the GLP-1 receptor. It remains an active area of scientific research and investigation.

Semaglutide has been investigated in preclinical and clinical research exploring incretin receptor signaling pathways related to metabolism and glucose homeostasis.

A batch-specific Certificate of Analysis is included with every shipment of this compound. Historical batch COAs are available from our documentation hub.